ITGA6 and glioblastoma: Data extracted from two distinct datasets of GBM patients [42,43] showed that ITGA6 expression was greater in GBMs compared with non-cancerous samples (Figure S1A) and that MES subtype expresses significantly higher levels of ITGA6 than PN GBMs (Figure S1B).